Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- To determine the antiviral efficacy of ledipasvir/sofosbuvir (LDV/SOF) +/- ribavirin (RBV) in subjects with chronic HCV infection as measured by the proportion of subjects in each treatment group with sustained viral response 12 weeks after discontinuation of therapy (SVR12) - To assess the safety and tolerability of LDV/SOF +/- RBV in subjects with chronic HCV infection as measured by review of the accumulated safety data
Critère d'inclusion
- Chronic hepatitis C virus infection